Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_assertion type Assertion NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_head.
- NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_assertion wasGeneratedBy ECO_0000203 NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_provenance.
- NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_assertion wasDerivedFrom befree-2016 NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_provenance.
- NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_assertion SIO_000772 17496201 NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_provenance.
- NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_assertion evidence source_evidence_literature NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_provenance.
- NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_assertion description "[Dasatinib, a novel, oral, multitargeted kinase inhibitor of BCR-ABL and SRC family kinases, has previously induced responses in patients with imatinib-resistant or -intolerant Ph-positive ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609456.RAf99SbHNqxWbmWJbGmhLA3FE3MrdHp6agw8cKraYPtaY130_provenance.